Aleukemic Acute Lymphoblastic Leukemia is a fast growing type of blood cancer in which the white blood cell count is not elevated in perioheral blood. The cancer can then spread to other organs in the body and without treatment Aleukemic Acute Lymphoblastic Leukemia will progress very quickly. This form of leukemia may arise from transformation of B or T cell progenitor cells. 60-80% of adults usually will achieve a complete remission, however if a patient experienced a relapse they more than likely will die within a year.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Aleukemic Acute Lymphoblastic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 45 products for the study of Aleukemic Acute Lymphoblastic Leukemia that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.